The FSMA's Intentional Adulteration (IA) rule was created to address intentional acts whose objective is to cause widespread harm to public health. (Courtesy photo)
In 2019, the U.S. Food and Drug Administration (FDA) announced that inspections of large businesses under the Intentional Adulteration (IA) rule would begin in March 2020 following a compliance date of July 2019. However, the COVID-19 pandemic required the FDA to postpone most routine inspections. As a result, the FDA announced they would halt all routine on-site surveillance inspections in the U.S. until March 2021. This was in an effort to verify a facility's compliance with the FDA Food Safety Modernization Act's IA rule.
Want to continue reading?
Become a Free PropertyCasualty360 Digital Reader
Your access to unlimited PropertyCasualty360 content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- All PropertyCasualty360.com news coverage, best practices, and in-depth analysis.
- Educational webcasts, resources from industry leaders, and informative newsletters.
- Other award-winning websites including BenefitsPRO.com and ThinkAdvisor.com.
Already have an account? Sign In
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
